# CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2020 · $3,997,467

## Abstract

The Clinical Trial Specimen Molecular Characterization (CTSMC) initiative will further the CCDI’s goals by providing molecular characterization of specimens from pediatric and AYA patients enrolled to NCI-funded clinical trials conducted by the PBTC, PEP-CTN, Pediatric CITN, and Children’s Oncology Group for use in the conduct of the trials and related correlative science studies.

## Key facts

- **NIH application ID:** 10281333
- **Project number:** 75N91019D00024-0-759102000021-1
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** ETHAN DMITROVSKY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $3,997,467
- **Award type:** —
- **Project period:** 2020-09-25 → 2025-09-24

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10281333

## Citation

> US National Institutes of Health, RePORTER application 10281333, CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM (75N91019D00024-0-759102000021-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10281333. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*